FDA inspectors found deficiencies in record-keeping and quality controls at Elon Musk's Neuralink during inspections of its animal research facilities. These issues come shortly after Neuralink received clearance for human testing of its brain implants. The inspections revealed missing calibration records and lapses in quality control, particularly at the California facility, while the Texas facility showed no issues. These findings raise concerns about Neuralink's attention to detail and its readiness for human trials, despite FDA approval based on the company's data.